comparemela.com

Unicorn Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UNICORN Study: Osimertinib and Other Emerging Treatments for Uncommon EGFR Mutations

Insights into how the UNICORN study, which assessed osimertinib, is impacting treatment decisions for uncommon EGFR mutations, and other ongoing trials shedding light on effective treatments for this patient population.

Precision medicineBiomarker testingNon small cell lung cancerLung cancerUnicorn studyUnicorn trialUncommon egfr mutationsExon 20 insertionsIntracranial diseaseExon 18 mutationsExon 21 mutations

Dr Franke on Treatment Options for NSCLC Expressing Uncommon EGFR Mutations

Aaron J. Franke, MD, MS, discusses treatment options for patients with uncommon EGFR mutations in non–small cell lung cancer.

Aaronj frankeUniversity of florida uf college medicineUf health cancer centerThoracic cancers disease site groupDivision of hematologyCancer centerThoracic oncologyOnclive tvNon small cell lung cancerLung cancerUncommon egfr mutationsDe novo and acquired exon 20 insertionsEgfr tyrosine kinase inhibitorUnicorn studyLux lung trials

vimarsana © 2020. All Rights Reserved.